Literature DB >> 23797034

Oxidative stress in atherosclerosis: the role of microRNAs in arterial remodeling.

Anna Zampetaki1, Katarzyna Dudek, Manuel Mayr.   

Abstract

Atherosclerosis is the underlying condition in most cardiovascular diseases. Among the highly specific cellular and molecular responses, endothelial dysfunction plays a key role in disease initiation and progression. These events coincide with the occurrence of oxidative stress. Increased reactive oxygen species production and oxidization of low-density lipoprotein are detected throughout atherosclerosis progression. MicroRNAs (miRNAs) have emerged as important regulators of gene expression that posttranscriptionally modify cellular responses and function. Accumulating studies indicate an integrated miRNA network in the molecular mechanisms that control cellular homeostasis, vascular inflammation, and metabolism. Experimental models of atherosclerosis highlight a direct link between altered miRNA expression profiles and the pathophysiology of the disease and identify putative miRNA candidates for the development of novel therapeutic strategies. In this review, we provide an overview of the role of miRNA regulatory networks in oxidative stress in atherosclerosis and arterial remodeling and discuss their potential therapeutic implications.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Free radicals; MiRNAs; Oxidative stress

Mesh:

Substances:

Year:  2013        PMID: 23797034     DOI: 10.1016/j.freeradbiomed.2013.06.025

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  21 in total

1.  Selective inactivation of NADPH oxidase 2 causes regression of vascularization and the size and stability of atherosclerotic plaques.

Authors:  I M Quesada; A Lucero; C Amaya; D N Meijles; M E Cifuentes; P J Pagano; C Castro
Journal:  Atherosclerosis       Date:  2015-08-08       Impact factor: 5.162

2.  Analysis of cardiovascular disease-related NF-κB-regulated genes and microRNAs in TNFα-treated primary mouse vascular endothelial cells.

Authors:  Hui Zhu; Yun Li; Mao-Xian Wang; Ju-Hong Wang; Wen-Xin Du; Fei Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2019 Oct.       Impact factor: 3.066

Review 3.  Vascular endothelial growth factor signaling in hypoxia and inflammation.

Authors:  S Ramakrishnan; Vidhu Anand; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-09       Impact factor: 4.147

Review 4.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

5.  Free-radical scavenging by tryptophan and its metabolites through electron transfer based processes.

Authors:  Adriana Pérez-González; Juan Raúl Alvarez-Idaboy; Annia Galano
Journal:  J Mol Model       Date:  2015-07-30       Impact factor: 1.810

Review 6.  Targeting vascular (endothelial) dysfunction.

Authors:  Andreas Daiber; Sebastian Steven; Alina Weber; Vladimir V Shuvaev; Vladimir R Muzykantov; Ismail Laher; Huige Li; Santiago Lamas; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

7.  MiR-155 acts as an inhibitory factor in atherosclerosis-associated arterial pathogenesis by down-regulating NoxA1 related signaling pathway in ApoE-/- mouse.

Authors:  Yu Tang; Haoming Song; Yuqin Shen; Yian Yao; Yunan Yu; Guolian Wei; Bangxiang Long; Wenwen Yan
Journal:  Cardiovasc Diagn Ther       Date:  2021-02

Review 8.  The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound Healing.

Authors:  João Moura; Elisabet Børsheim; Eugenia Carvalho
Journal:  Genes (Basel)       Date:  2014-09-29       Impact factor: 4.096

9.  Liraglutide reduces oxidized LDL-induced oxidative stress and fatty degeneration in Raw 264.7 cells involving the AMPK/SREBP1 pathway.

Authors:  Yan-Gui Wang; Tian-Lun Yang
Journal:  J Geriatr Cardiol       Date:  2015-07       Impact factor: 3.327

10.  Notoginsenoside R1 attenuates atherosclerotic lesions in ApoE deficient mouse model.

Authors:  Chenglin Jia; Minqi Xiong; Peiwei Wang; Jingang Cui; Xiaoye Du; Qinbo Yang; Wenjian Wang; Yu Chen; Teng Zhang
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.